CN Patent
CN102803260A — 被取代的多环性氨基甲酰基吡啶酮衍生物
Assigned to Shionogi and Co Ltd · Expires 2012-11-28 · 13y expired
What this patent protects
本发明提供了具有抗病毒作用、特别是具有流感病毒的増殖抑制活性的化合物。更优选地,提供了显示帽依赖性内切核酸酶抑制活性的、被取代的3-羟基-4-吡啶酮衍生物。
USPTO Abstract
本发明提供了具有抗病毒作用、特别是具有流感病毒的増殖抑制活性的化合物。更优选地,提供了显示帽依赖性内切核酸酶抑制活性的、被取代的3-羟基-4-吡啶酮衍生物。
Drugs covered by this patent
- Xofluza (BALOXAVIR MARBOXIL) · Roche
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.